• Home
  • Primary endpoints to assess the efficacy of novel therapeutic approaches in epidermal growth factor receptor-mutated, surgically resectable non-small cell lung cancer: A review.

Primary endpoints to assess the efficacy of novel therapeutic approaches in epidermal growth factor receptor-mutated, surgically resectable non-small cell lung cancer: A review.

Author List
Blakely CM, Weder W, Bubendorf L, He J, Majem M, Shyr Y, Chaft JE
Publication
Lung cancer (Amsterdam, Netherlands)
Publication ID (Profile URL)
https://researcherprofiles.org/profile/365784497
Publication Year
2023
PubMed ID
36736076
Publication Title
Blakely CM, Weder W, Bubendorf L, He J, Majem M, Shyr Y, Chaft JE. Primary endpoints to assess the efficacy of novel therapeutic approaches in epidermal growth factor receptor-mutated, surgically resectable non-small cell lung cancer: A review. Lung Cancer. 2023 03; 177:59-72.